newsfilter
← Latest News
GlobeNewswire·

Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO'22

SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that two presentations with patient data on indi